KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

VivoSim Labs (VIVS) Research & Development (2016 - 2025)

VivoSim Labs (VIVS) has 15 years of Research & Development data on record, last reported at $1.1 million in Q4 2025.

  • For Q4 2025, Research & Development fell 35.96% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $3.9 million, down 24.98%, while the annual FY2025 figure was $5.0 million, 8.6% down from the prior year.
  • Research & Development reached $1.1 million in Q4 2025 per VIVS's latest filing, up from $923000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $5.4 million in Q1 2023 and bottomed at $580000.0 in Q2 2021.
  • Average Research & Development over 5 years is $1.3 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Research & Development: skyrocketed 2325.0% in 2021, then tumbled 80.49% in 2024.
  • A 5-year view of Research & Development shows it stood at $926000.0 in 2021, then grew by 27.97% to $1.2 million in 2022, then increased by 21.01% to $1.4 million in 2023, then increased by 24.13% to $1.8 million in 2024, then tumbled by 35.96% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $1.1 million in Q4 2025, $923000.0 in Q3 2025, and $1.0 million in Q2 2025.